Microalgae DHA Market Overview
The microalgae DHA market size is estimated to reach $4.9 billion by 2027. Furthermore, it is poised to grow at a CAGR of 6.5% over the forecast period of 2022-2027. Microalgae DHA is a long-chain omega-3 polyunsaturated fatty acid supplementation that provides therapeutic and medical benefits to consumers. Similar to the omega-3 found in fish oil, the omega 3 sources from the microalgae contain similar nutritional value and oxidative stability. Moreover, they are termed vegan, as algae belong to the plant family. Moreover, the DHA helps the body in maintaining the existing functions and helps in developing a strong immune system. Additionally, fish oil has gained immense popularity, but researchers believe that the value of DHA can vary as per species of fish and what they consume. Fishes, on the other hand, are incapable of producing the omega 3 fats and are dependent on the micro-algae. Hence, micro-algae DHA is positioned at the starting point of the marine food chain. Bio-molecular companies are actively deploying R&D functionalities to take it from the source.
The rising use of micro-algae DHA-based products for treating cardiovascular ailments and the chemical properties of the DHA obtained from the microalgae which are independent of the weather change and fluctuation are some of the factors driving the microalgae DHA industry forward.
The report: “Microalgae DHA Market Forecast (2022-2027)”, by Industry ARC covers an in-depth analysis of the following segments of the Sugar Alcohol Market.
By Type- DHA Powder, DHA Oil, and Others.
By Distribution Channel- Hypermarkets and Supermarkets, Grocery Stores, Online Retail Stores, and Others.
By End Users- Consumers, Food Manufacturers, Nutraceutical Manufacturers, Cosmetics Manufacturers, Pharmaceutical Manufacturers, and Animal Feed Manufacturers.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), and Rest of the World (the Middle East, and Africa)
- Geographically, North America held a dominant market share in the year 2021. It is owing to the use of microalgae in supplements to help during a disease (cardiovascular) predominantly. However, Asia-Pacific is set to grow at a lucrative pace owing to the use of DHA across age groups to benefit. Moreover, it helps in providing the body with a regular source of polyunsaturated fats.
- The rising use of micro-algae-based products to treat the increasing cardiovascular cases will drive the market. However, the alternative-fish oil-based DHA has a market reputation that acts as a challenge to address.
- Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Microalgae DHA market report.
Microalgae DHA Market Segment- By Geography (%) for 2021.
For More Details on This Report - Request for Sample
Microalgae DHA Market Segment Analysis- By End Users
The microalgae DHA market based on end-users is further segmented into Consumers, Food Manufacturers, Nutraceutical Manufacturers, Cosmetics Manufacturers, Pharmaceutical Manufacturers, and Animal Feed Manufacturers. The food manufacturers held the largest market share in the year 2021. It is owing to the use of microalgae in making various infant formulas and other beverages. Moreover, as per various research, the cell wall of the algae is relatively thin, and the oxidative stability is subsequently high, thereby making commercial production easier while making multiple food and beverages. Moreover, various product inventions are seen in the following; additionally, they are cultured in pure water to eliminate contamination by up to 98%.
However, the nutraceutical manufacturers segment is estimated to be the fastest-growing, with a CAGR of 7.8% over the forecast period of 2022-2027. It is owing to various health benefits the product offers. Moreover, the rising trend to obtain nutrition via vegan routes will propel the market forward. Additionally, multiple manufacturers have reported that fish oil is immensely affected by what they eat and has plastic material in their guts, making them void to be used.
Microalgae DHA Market Segment Analysis- By Distribution Channel
The microalgae DHA market based on distribution channels can be further segmented into Hypermarkets, Supermarkets, Grocery Stores, Online Retail Stores, and Others. The hyper and supermarkets held the largest share in the year 2021. It is owing to the availability of various microalgae products on the shelves of such models, making it easier to make a choice. Additionally, the following distribution channel offers customers lucrative discounts based on the billing of "healthy" food items and supplements.
However, the online retail store's segment is estimated to be the fastest-growing, with a CAGR of 7.3% over the forecast period of 2022-2027. It is owing to the manufacturer's choice to eliminate various subsidiaries from the middle and directly offer products to the consumers. Additionally, lucrative discounts, cash backs, and wallet money are some of the strategies being commonly adopted by the following channel to grow ahead of the primitive models. For example, a discount of 10% can be availed from True Basics while making an online purchase, while no such discounts can be availed from the bring and mortar stores.
Microalgae DHA Market Segment Analysis- By Geography
The Microalgae DHA market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World.
North America’s microalgae DHA market held a 36% market share as compared to the other regions in 2021. It owes to the fast-changing preference of people to gain daily nutritional value via vegan sources, then meat sources. For example, 0.5% of the population was termed vegan; now, around 6% have been surveyed as a vegan in the USA. The following trend has been reflected in the change in dietary intake via healthy and vegan sources.
However, the Asia-Pacific is set to grow at a lucrative pace during the forecast period of 2022-2027. It is owing to the increase in sedentary lifestyle habits, which are supported by the growing urbanization. In addition, the regions of India and China are attributed to being of the fastest-growing economies. Hence, with the rise of the working population, the cardiovascular risks increase, which can be substantially cured by taking the microalgae DHA supplements.
Microalgae DHA Market Drivers
The use of microalgae as a supplement to help in treating cardiovascular diseases is promoting the market growth
Cardiovascular diseases have become prevalent in the economies around, moreover, a trend of high cardiovascular diseases has been noticed in countries with high HDI. For example, the USA CDC believes and estimates that 10 million deaths, annually are related to ailments such as hypertension and diabetes. Furthermore, the USA observes 1 in 4 deaths owing to heart ailments. The use of microalgae DHA has proven omega three and omega 6, which led to the production of essential lipids, which are easier to break down due to no cell walls. Nutritionally, eicosapentaenoic acid and docosahexaenoic acid are the essential fatty acids belonging to this group of bioactive compounds. These long-chain omega-3 fatty acids provide significant health benefits to the human population, particularly in reducing cardiac diseases such as arrhythmia, stroke, and high blood pressure.
Micro-algae exhibit the chemical properties- while fishes consume them- hence obtaining EPA and DHA from source offers more sustainable DHA and EPA driving product demand
Fishes do not produce the DHA and EPA directly; instead, they obtain it by eating the small fish and consuming various forms of algae. According to the U.S. Department of Health and Human Services, EPA and DHA typically comprise about 3% – 5% of erythrocyte fatty acids in Western populations with low fish intakes. Hence, fishes come towards the end of the food chain. Researchers believe that obtaining the DHA and EPA from the base source or origin will provide a healthier level of DHA and EPA. Moreover, the extraction of fish oil is highly different by the type of fish used, the area in which they were taken, and furthermore, each variety of fish will contain dynamic levels of DHA and EPA. Autotrophic microalgae do not require an organic carbon source and hence may avoid the problems faced by heterotrophic(fishes) cultures that can easily get contaminated with other microorganisms.
Microalgae DHA Market Challenges
Fish oil provides equal competition for microalgal oil and poses a challenge for the market
Fish oil has always had a market presence owing to its many benefits, such as supporting heart health by reducing LDL, controlling blood pressure levels, and, more importantly, treating certain mental disorders. Furthermore, it has been in use for a predominant time, making it a go-to product for many consumers. On the other hand, microalgal oil although offers superior or at par nutritional value still faces tough challenges during extraction and production. Industrialists and researchers are still trying to find better methods that can substantially decrease the costs by up to 15 - 25% and make the products at par with fish oil-based supplements. Moreover, 90 capsules of fish oil can cost up to INR 1000, while 90 capsules of algal oil can cost up to 1699. The following shows the price gap affluence by high production costs.
Microalgae DHA Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the microalgae DHA Market. The top 10 microalgae DHA market companies are-
- Goerlich Pharma GmbH,
- Nordic Naturals, Inc.,
- InovoBiologic Inc.,
- Source Omega LLC,
- The 3rd Opinion Inc.,
- Deva Nutrition LLC, Cellana Inc.,
- Xiamen Huison Biotech Co.,
- Ltd, Kangcare Bioindustry Co., Ltd.,
- Shandong Yuexiang Biotechnology Co., Ltd., and
- Hubei Ruiren Biotechnology Co., Ltd.
- In September 2021, Free Spirit Group added a product line to its infant formula. The formula would contain 250 mg of DHA and 2.5 mg of EPA per serving of 0.5 mL. It is sourced from the Schizochytrium strain.
- In June 2021, Polaris launched Omegavie DHA 800 algal quality silver oil. The following is directly sourced from Schizochytrium. Moreover, it contains 800mg/ gram of DHA and other required PUFA.
Report Code- FBR 0262
Report Code- AGR 0021
Report Code: FBR 60755
For more Food and Beverage Market reports, please click here